Meet our team

5AM’s investment professionals possess strong scientific, medical, operational, legal and financial expertise. Our complementary backgrounds provide us with a unique edge to find and shape life science portfolio companies.

Investment Team

Kush M Parmar, MD, PhD

Managing Partner
Andy J. Schwab

Managing Partner
Michael Calore

Partner, Head of Investor Relations
Brian Daniels, MD

Partner
Deborah Palestrant, PhD

Partner and Executive Chair, 4:59 Initiative
Paul A. Stone, JD

Partner, Chief Legal Officer
Anna Yaeger

Partner and Head of Public Equities
Nicoletta Agostino

Senior Financial Analyst
Lindsay Ziegler Antonio

Compliance Manager
Anthony Arceci, PhD

Research Analyst
Kamila Bajerski

Assistant Controller
Andrew Booth

Venture Advisor
Jacquelyn Brough, CPA

Senior Vice President, Finance
Caroline Chamales

Executive Assistant
Kevin Corsini Rosewood

Office Manager and Administrative Assistant
Lauren Daniel, JD

Chief Compliance Officer and Deputy General Counsel
Gisella de la Rocha, JD

Senior Corporate Counsel, 4:59 Initiative
John D. Diekman, PhD

FOUNDING PARTNER
Britt Inga Emerson

Investor Relations Manager
Max Farina, MD

Principal
Mason Freeman, MD

Venture Partner
Steve Hitchcock, PhD

Venture Partner
Jane Johnstone

Legal Manager
Peter S. Kim, PhD

Venture Advisor
Jennifer Kozub

Operations Manager and Executive Assistant
Elliott Levy, MD

Venture Partner
Jack Liu, PhD

Senior Research Analyst
Joe Loscalzo, MD, PhD

Venture Advisor
Vamsi Mootha, MD

Venture Advisor
Bella Nittolo

Office Coordinator and Administrative Assistant
Kori Rahaim

Vice President, Head of People, 4:59 Initiative
Scott M. Rocklage, PhD

FOUNDING PARTNER
Paula Soteropoulos

Venture Partner
Katie Bodner Spielberg, PhD

Principal
Brian Stefanowicz, CPA

Controller
Aniqa Tasnim, PhD

Associate
Arthur Tzianabos, PhD

Venture Partner
Joseph J. Victor

Venture Advisor
Jenny Wang, CPA

Director, Tax
Jonathan Weissman, PhD

Venture Advisor